TIG Advisors LLC’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

TIG Advisors LLC’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,057,892	Closed	-$140M	–	87
2025 Q1	$140M	Buy	+1,057,892	New	+$132M	8.73%	3

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TIG Advisors LLC's ITCI Position: Q2 2025 in Review

TIG Advisors LLC sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 1,057,892 shares — an estimated $140M sold.

TIG Advisors LLC first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $140M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

TIG Advisors LLC reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
TIG Advisors LLC sold 1,057,892 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $140M.
TIG Advisors LLC first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
TIG Advisors LLC's Intra-Cellular Therapies Inc. position peaked at $140M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on TIG Advisors LLC's 13F filing for Q2 2025, filed 14 Aug 2025.